1 results about "Viral Receptor" patented technology

This invention belongs to the field of biomedical engineering technology, specifically relating to the construction and application of a screening model for influenza virus receptor binding inhibitors. Addressing the problem of influenza virus hemagglutinin (HA) being prone to mutation and having multiple subtypes, making it difficult to screen for broad-spectrum inhibitors, this invention replaces HA with elderberry lectin (SNA), which specifically recognizes α-2,6-sialic acid. Using MDCK cells overexpressing α-2,6-sialic acid, a fluorescently labeled high-throughput screening model is constructed by labeling SNA with fluorescein isothiocyanate (FITC). The relative fluorescence units (RFU) of the system are detected using a multifunctional enzyme-linked immunosorbent assay (ELISA) reader. Active compounds inhibit the binding of SNA to cell surface receptors, resulting in a lower RFU value, while inactive compounds show a higher RFU value. This invention provides key technical support for the development of novel inhibitors targeting influenza virus receptor binding.